MOTS-c
A mitochondrial-derived peptide that activates AMPK, the master metabolic switch. Described as an exercise mimetic — improves glucose uptake and fatty acid oxidation.
Quick Reference
- Primary effects
- Energy Boost
- Onset
- Days-weeks (cumulative)
- Duration
- Ongoing with protocol
- Intensity
- Subtle
- Legal status
- Legal (US)
- Evidence level
- Community consensus
Key Compounds
What it is
MOTS-c is a mitochondrial-derived peptide that gained attention in longevity research circles before migrating to biohacking communities. The peptide consists of 16 amino acids encoded by the mitochondrial genome — making it one of the few bioactive compounds our cellular powerhouses produce directly [1]. Originally discovered by researchers studying mitochondrial dysfunction and aging, MOTS-c showed an unusual ability to regulate metabolism at the cellular level.\n\nToday, we see MOTS-c used primarily by individuals seeking metabolic optimization without traditional stimulants. The peptide's reputation as an "exercise mimetic" stems from its ability to activate AMPK — the same metabolic pathway triggered by endurance exercise and caloric restriction [2]. Unlike synthetic metabolic enhancers, MOTS-c works by enhancing existing cellular machinery rather than overriding it.\n\nWhat sets MOTS-c apart in the peptide space is its dual action on both glucose and fat metabolism. Users typically integrate it into broader metabolic protocols, often combining it with specific dietary approaches or exercise regimens. The peptide requires consistent administration over weeks to months, making it unsuitable for acute interventions.
Effects
What you're here for
The Science
Content generated via CMS — mechanism of action, pharmacology, and research summaries will appear here.
Dosage
Content generated via CMS — dosage tiers, timing recommendations, and form-specific guidance will appear here.
Forms & How to Use
Content generated via CMS — available forms (powder, capsule, tincture, etc.) and preparation guidance will appear here.
Safety
Content generated via CMS — contraindications, interactions, and safety profile information will appear here.
Health Disclaimer: This information is for educational purposes only and is not medical advice. Consult a qualified healthcare provider before using any substance, especially if you take medications or have a medical condition.
Legal Status
An interactive legal status map will appear here. Check legality by state and country.
Trusted Vendors
Vendor listings coming soon. We vet every vendor for third-party testing, GMP compliance, and transparent sourcing.
Key Compounds
Featured In
JRE #2461 — RFK Jr. Announces FDA Peptide Reclassification
by Joe Rogan & Robert F. Kennedy Jr. · Feb 27, 2026
“MOTS-c included in the 14 peptides moving back to Category 1 compounding status.”
Sources & Citations
Content generated via CMS — peer-reviewed references, clinical trials, and source links will appear here.